Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
SAI Life Sciences Ltd. ( (IN:SAILIFE) ) has issued an announcement.
Sai Life Sciences Ltd. has received an order from the Joint Commissioner of Commercial Taxes (Appeals) regarding a demand for IGST, interest, and penalty related to intermediary services received from its subsidiary in the USA. The company plans to appeal the order and does not anticipate any material financial impact from this development.
More about SAI Life Sciences Ltd.
Sai Life Sciences Ltd. operates in the pharmaceutical industry, focusing on providing contract research, development, and manufacturing services to global pharmaceutical and biotechnology companies.
Average Trading Volume: 66,879
Technical Sentiment Signal: Strong Buy
Current Market Cap: 181.7B INR
For detailed information about SAILIFE stock, go to TipRanks’ Stock Analysis page.